abstract |
The present invention relates to novel isoquinoline derivatives of formula (I), their synthesis and their use in the prevention and/or treatment of diseases caused by activation of the RhoA/ROCK pathway and phosphorylation of myosin light chains, wherein X represents a group -C(=O), -CH(OH)- or -CH 2 -, and other substituents represent various groups as defined in claim 1. |